Tony Marson, EAN 2019 – Improving epilepsy care and patient outcomes
We had an opportunity to catch up with EAN Programme Committee Chair Tony Marson (Liverpool, UK), who talked to us on the topic of the special session he moderated entitled: How to use ‘big data’ and digital technology to improve epilepsy care and patient outcomes.
1. What have we learned from audits about the costs of inadequately coordinated care in epilepsy? (0:04)
2. How can the use of ‘big data’ help neurologists in making point-of-care decisions? (1:54)
3. What are the most useful components of a ‘pathways of care’ approach in epilepsy services? (3:00)
4. What are the major barriers in implementing such approaches? (4:12)
5. Could you tell us a little about the European Brain Council (EBC) Value of Treatment of Epilepsy project? (4:36)
Speaker disclosure: UCB Pharma funded the UK audit discussed in this video interview.
Filmed at the 5th Congress of the European Academy of Neurology (EAN), Oslo, Norway, June 2019.
Share this Video
Related Videos In Epilepsy
Jacqueline French, AAN 2023: XEN1101, a novel potassium channel modulator for the treatment of focal epilepsy
In this interview with touchNEUROLOGY, Prof. Jacqueline French (Comprehensive Epilepsy Center, New York University, New York, NY, US) discusses the needs of adults with focal epilepsy and the mechanisms of action of XEN1101, a novel, potent, selective Kv7.2/7.3 potassium channel. The abstract entitled “XEN1101, a Novel Potassium Channel Modulator: Interim Data From an Ongoing, Long-Term, […]
Jacqueline French, AAN 2023: X-TOLE phase 2b open-label extension trial of XEN1101 in focal epilepsy – interim data
The randomized, double-blind, placebo-controlled phase IIb study X-TOLE (NCT03796962) is investigating the efficacy of XEN1101, a novel potassium channel modulator, in adults with focal epilepsy. In this interview with touchNEUROLOGY, Prof. Jacqueline French (Comprehensive Epilepsy Center, New York University, New York, NY, US) discusses this clinical trial and the outcomes of its open-label extension. The […]
Galia Wilson, Dravet Syndrome UK: DSUK Objectives, directions and support for families and people living with Dravet syndrome
Dravet Syndrome (DS) is a rare neurological condition, beginning in infancy and lasting a lifetime. touchNEUROLOGY were joined by Galia Wilson, Chair and Trustee of Dravet Syndrome UK (DSUK), a charity created in 2008 by a group of parents who came together looking for support, resources and information relating to the neurological condition. In this interview, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!